0001062993-22-022769.txt : 20221125 0001062993-22-022769.hdr.sgml : 20221125 20221125091134 ACCESSION NUMBER: 0001062993-22-022769 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221125 DATE AS OF CHANGE: 20221125 EFFECTIVENESS DATE: 20221125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Thiogenesis Therapeutics, Corp. CENTRAL INDEX KEY: 0001877778 IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-465814 FILM NUMBER: 221418030 BUSINESS ADDRESS: STREET 1: 4 KING STREET WEST, SUITE 401 CITY: TORONTO STATE: A6 ZIP: M5H 1B6 BUSINESS PHONE: 6478467766 MAIL ADDRESS: STREET 1: 4 KING STREET WEST, SUITE 401 CITY: TORONTO STATE: A6 ZIP: M5H 1B6 FORMER COMPANY: FORMER CONFORMED NAME: Rozdil Capital Corp DATE OF NAME CHANGE: 20210810 D 1 primary_doc.xml X0708 D LIVE 0001877778 Thiogenesis Therapeutics, Corp. 4 KING STREET WEST, SUITE 401 TORONTO A6 ONTARIO, CANADA M5H 1B6 420 776659259 ONTARIO, CANADA Rozdil Capital Corp Corporation true 2018 Brook Riggins 4 King Street West, Suite 401 Toronto A6 ONTARIO, CANADA M5H 1B6 Executive Officer Director Patrice Rioux 4 King Street West, Suite 401 Toronto A6 ONTARIO, CANADA M5H 1B6 Executive Officer Director Hogan W. Mullally 4 King Street West, Suite 401 Toronto A6 ONTARIO, CANADA M5H 1B6 Director Kim Tsuchimoto 4 King Street West, Suite 401 Toronto A6 ONTARIO, CANADA M5H 1B6 Director Christopher Starr 4 King Street West, Suite 401 Toronto A6 ONTARIO, CANADA M5H 1B6 Director Other Decline to Disclose 06b false 2022-11-18 false true false 0 218303 218303 0 U.S. dollar amounts are based on the Bank of Canada exchange rate 0.7471 reported on November 18, 2022 false 3 0 0 0 false Thiogenesis Therapeutics, Corp. /s/ Brook G. Riggins Brook G. Riggins CFO 2022-11-25